Li, Jing <br/><br/>
IL33 attenuates ventricular remodeling after myocardial infarction through inducing alternatively activated macrophages ethical standards statement.  [electronic resource] 

 -  European journal of pharmacology  Jul 2019 
 - 307-319 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2019.04.046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Interleukin-33--pharmacology<br/>Janus Kinases--metabolism<br/>Macrophage Activation--drug effects<br/>Macrophages--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Myocardial Infarction--immunology<br/>Myocardium--metabolism<br/>RAW 264.7 Cells<br/>STAT Transcription Factors--metabolism<br/>Signal Transduction--drug effects<br/>Ventricular Remodeling--drug effects